The original shielding letters and advice that have been sent out to people who are highly vulnerable to COVID-19 (coronavirus) infection stated that all recipients of the letter should completely isolate themselves from physical contact, not go outside of their homes for 12 weeks.
This advice was sent to all patients of the National Aspergillosis Centre (NAC) who have chronic pulmonary aspergillosis (CPA).
Patients who have allergic bronchopulmonary aspergillosis (ABPA), severe asthma and forms of aspergillosis other than CPA were informed of their vulnerability status by their local respiratory clinic or GP. Some will have been told to shield, others not but all shielding advice was to remain in place for 12 weeks from the day of receipt of the letter.
That advice for people shielding has now been amended to say that all shielding people should continue shielding until the end of June 2020.
Latest advice from Welsh government
Share this post
Latest News posts
The Benefits of Peer Support
March 25, 2023
2023 Bronchiectasis Patient Conference
March 23, 2023
Fungal vaccine developments
March 22, 2023
Asthma UK’s End the Lung Health Lottery
March 21, 2023
Secondary Adrenal Insufficiency
March 17, 2023
IgG and IgE explained
March 14, 2023
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video